Vera Therapeutics Inc is a clinical stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VERA is expected to report earnings to rise 5.92% to -161 cents per share on November 11
Q3'26
Est.
$-1.61
Q2'26
Beat
by $0.13
Q1'26
Missed
by $0.36
Q4'25
Missed
by $0.11
Q3'25
Missed
by $0.11
The last earnings report on August 10 showed earnings per share of -151 cents, beating the estimate of -164 cents. With 640.69K shares outstanding, the current market capitalization sits at 2.33B.